Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Variable descriptions.

More »

Table 1 Expand

Table 2.

GLMM regression of annual per-patient HIV treatment costs on proximal cost determinants.

More »

Table 2 Expand

Table 3.

Change in annual per-patient cost for established adult ART patients associated with changes in individual cost determinants.

More »

Table 3 Expand

Figure 1.

Change in annual per-patient cost for established adult ART patients as a function of site maturity and patient volume.

Panel A shows annual HIV treatment cost as a function of site maturity. Panel B shows annual HIV treatment cost as a function of patient volume. HIV treatment costs represent annual economic costs of site-level service delivery in 2010 US dollars, excluding ARVs and national/regional overhead costs. Changes in per-patient costs calculated from a regression of per-patient costs against proximal cost determinants. Each panel shows the consequence of change in a single determinant, holding all other determinants at their mean values.

More »

Figure 1 Expand

Figure 2.

Change in annual per-patient cost for established adult ART patients as a function of per-capita GDP.

HIV treatment costs represent economic costs of site-level service delivery in 2010 US dollars, excluding ARVs and national/regional overhead costs. Changes in per-patient costs calculated from a regression of per-patient costs against proximal cost determinants. The plot shows the consequence of changes in per-capita GDP, holding all other determinants at their mean values. Overplotted country-level estimates: ETH = Ethiopia, MOZ = Mozambique, UGA = Uganda, VIE = Vietnam, NIG = Nigeria, BOT = Botswana.

More »

Figure 2 Expand

Figure 3.

Average annual per-patient HIV treatment costs, by patient type.

HIV treatment costs represent economic costs of site-level service delivery in 2010 US dollars, excluding ARVs and national/regional overhead costs. Cost estimates calculated from a regression of per-patient costs against proximal cost determinants. In figure, diamond signifies point estimate, length of bars signifies 95% confidence interval.

More »

Figure 3 Expand

Table 4.

GLMM regression of annual per-patient HIV treatment costs against distal cost determinants, with three model specifications.

More »

Table 4 Expand